Attenuating mutations in coxsackievirus B3 map to a conformational epitope that comprises the puff region of VP2 and the knob of VP3.

Attenuating mutations in coxsackievirus B3 map to a conformational epitope that comprises the puff region of VP2 and the knob of VP3.

Item
http://www.wikidata.org/entity/Q37683219
Mutations in the 5' NTR and the Non-Structural Protein 3A of the Coxsackievirus B3 Selectively Attenuate MyocarditogenicityThe Crystal Structure of a Coxsackievirus B3-RD Variant and a Refined 9-Angstrom Cryo-Electron Microscopy Reconstruction of the Virus Complexed with Decay-Accelerating Factor (DAF) Provide a New Footprint of DAF on the Virus SurfaceA novel universal neutralizing monoclonal antibody against enterovirus 71 that targets the highly conserved "knob" region of VP3 protein.Identification and typing of human enterovirus: a genomic barcode approachCharacterization of attenuated coxsackievirus B3 strains and prospects of their application as live-attenuated vaccines.The whole genome sequence of coxsackievirus B3 MKP strain leading to myocarditis and its molecular phylogenetic analysis.Interactions between multiple genetic determinants in the 5' UTR and VP1 capsid control pathogenesis of chronic post-viral myopathy caused by coxsackievirus B1Basic rationale, current methods and future directions for molecular typing of human enterovirus.Molecular determinants of disease in coxsackievirus B1 murine infection.Intracerebral inoculation of mouse-passaged Saffold virus type 3 affects cerebellar development in neonatal mice.Genotyping of human rhinovirus in adult patients with acute respiratory infections identified predominant infections of genotype A21.Role of RNA structure motifs in IRES-dependent translation initiation of the coxsackievirus B3: new insights for developing live-attenuated strains for vaccines and gene therapy.A novel pancreatropic coxsackievirus vector expressing glucagon-like peptide 1 reduces hyperglycemia in streptozotocin-treated mice.Recent advances from studies on the role of structural proteins in enterovirus infection.Complete genome sequence of a coxsackievirus B3 recombinant isolated from an aseptic meningitis outbreak in eastern China.Mapping of a quantitative trait locus controlling susceptibility to Coxsackievirus B3-induced viral hepatitis.A genetically engineered attenuated coxsackievirus B3 strain protects mice against lethal infection.
P2860

Attenuating mutations in coxsackievirus B3 map to a conformational epitope that comprises the puff region of VP2 and the knob of VP3.

Item
http://www.wikidata.org/entity/Q37683219
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2004
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Attenuating mutations in coxsa ...... on of VP2 and the knob of VP3.
@en
Attenuating mutations in coxsa ...... on of VP2 and the knob of VP3.
@nl
type
label
Attenuating mutations in coxsa ...... on of VP2 and the knob of VP3.
@en
Attenuating mutations in coxsa ...... on of VP2 and the knob of VP3.
@nl
prefLabel
Attenuating mutations in coxsa ...... on of VP2 and the knob of VP3.
@en
Attenuating mutations in coxsa ...... on of VP2 and the knob of VP3.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P698
P921
P932
P356
P1433
P1476
Attenuating mutations in coxsa ...... on of VP2 and the knob of VP3.
@en
P2093
P2860
P304
P31
P356
10.1128/JVI.78.24.13987-14002.2004
P407
P433
P478
P577
P698
P921
P932